Diana Bilton Selected Research

Diana Bilton Research Topics

Disease

38	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 03/2005
15	Bronchiectasis 01/2019 - 11/2006
10	Infections 01/2020 - 11/2006
4	Pseudomonas Infections 11/2021 - 11/2006
2	Exocrine Pancreatic Insufficiency 01/2022 - 09/2008
2	Disease Progression 01/2020 - 01/2018
2	Respiratory Insufficiency (Respiratory Failure) 01/2019 - 05/2015
2	Persistent Infection 06/2015 - 05/2009
2	Cough 03/2015 - 06/2011
2	Lung Diseases (Lung Disease) 01/2014 - 02/2012
2	Liver Diseases (Liver Disease) 02/2010 - 09/2008
1	Meconium Ileus 01/2022
1	Neoplasms (Cancer) 01/2022
1	Gastroesophageal Reflux (GERD) 01/2022
1	Metabolic Bone Diseases (Osteopenia) 01/2021
1	Rare Diseases (Rare Disease) 01/2018
1	Cross Infection (Nosocomial Infection) 01/2017
1	Fatigue 05/2015
1	Cardiotoxicity 10/2014
1	Ototoxicity 10/2014
1	Inflammation (Inflammations) 01/2014
1	Asthma (Bronchial Asthma) 06/2011
1	Chronic Obstructive Pulmonary Disease (COPD) 05/2011
1	Osteoporosis 03/2010
1	Necrosis 03/2010
1	Staphylococcal Infections 02/2010
1	Allergic Bronchopulmonary Aspergillosis 02/2010
1	Burkholderia Infections 02/2010
1	Bone Resorption 08/2006
1	Emphysema 06/2002

Drug/Important Bio-Agent (IBA)

13	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 05/2009
6	Mannitol (Osmitrol)FDA LinkGeneric 03/2015 - 02/2012
4	ivacaftorIBA 01/2022 - 01/2018
4	Tobramycin (Nebcin)FDA LinkGeneric 11/2021 - 11/2006
4	SolutionsIBA 11/2021 - 11/2006
3	Liposomes (Liposome)IBA 11/2021 - 09/2015
3	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2019 - 11/2006
3	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2010 - 09/2008
2	SuspensionsIBA 11/2021 - 01/2020
2	Amikacin (A.M.K)FDA LinkGeneric 11/2021 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2018
2	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2018 - 09/2008
2	Aztreonam FDA LinkGeneric 11/2017 - 03/2013
2	Lysine (L-Lysine)FDA Link 11/2017 - 03/2013
2	DNA (Deoxyribonucleic Acid)IBA 09/2015 - 03/2014
2	PowdersIBA 03/2015 - 07/2013
2	Expectorants (Mucolytics)IBA 11/2014 - 01/2014
2	CytokinesIBA 03/2010 - 08/2006
1	Proton Pump InhibitorsIBA 01/2022
1	colistinmethanesulfonic acid (colistimethate sodium)FDA LinkGeneric 01/2021
1	EnzymesIBA 01/2021
1	16S Ribosomal RNAIBA 01/2017
1	NucleotidesIBA 01/2017
1	AerosolsIBA 11/2016
1	PorinsIBA 06/2015
1	AntigensIBA 06/2015
1	Immunodominant EpitopesIBA 06/2015
1	VaccinesIBA 06/2015
1	dornase alfa (Pulmozyme)FDA Link 11/2014
1	MacrolidesIBA 10/2014
1	Colistin (Coly-Mycin)FDA Link 04/2014
1	amelubantIBA 03/2014
1	Leukotriene B4IBA 03/2014
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	Azithromycin (Zithromax)FDA LinkGeneric 10/2013
1	2-(4-toluidino)-6-naphthalenesulfonic acid (TNS)IBA 03/2013
1	Oral ContraceptivesIBA 01/2013
1	Glucose (Dextrose)FDA LinkGeneric 07/2011
1	SmokeIBA 05/2011
1	LigandsIBA 03/2010
1	collagen type I trimeric cross-linked peptideIBA 03/2010
1	Collagen Type I (Type I Collagen)IBA 03/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2010
1	OsteocalcinIBA 03/2010
1	Interleukin-6 (Interleukin 6)IBA 03/2010
1	OsteoprotegerinIBA 03/2010
1	dimemorfan (AT 17)IBA 11/2006
1	Leukocyte Elastase (Neutrophil Elastase)IBA 02/2006
1	Peptide Hydrolases (Proteases)FDA Link 02/2006
1	PolymersIBA 06/2002

Therapy/Procedure

11	Therapeutics 01/2019 - 02/2006
3	Noninvasive Ventilation 01/2019 - 05/2015
1	Transplantation 01/2022
1	Patient Admission (Patient Admissions) 05/2015
1	Dry Powder Inhalers 01/2014
1	Nebulizers and Vaporizers (Inhaler) 03/2013
1	Physical Therapy Modalities (Physical Therapy Technique) 06/2012
1	Aftercare (After-Treatment) 03/2010
1	Organ Transplantation 02/2010
1	Terminal Care (Care, Terminal) 12/2005
1	Kidney Transplantation 03/2005